J.P. Galda & Co.
Attorneys-at-Law
40 East Montgomery Avenue, LTW 220
Ardmore, Pennsylvania 19003
Telephone (215) 815-1534
January 28, 2022
Via Edgar
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
Re: Revelation Biosciences, Inc.
Ladies and Gentlemen:
Today Revelation Biosciences, Inc. is filing a selling securityholder Registration Statement pursuant to registration rights granted to the purchaser in a recently completed PIPE transaction. The Company has recently completed a de-SPAC transaction in which the disclosure regarding the Company received a full review. The only changes to the disclosure relate to the change in form, the PIPE transaction description, and to reflect the impact of the de-SPAC transaction. As a result, we would like to become effective prior to the financial statements becoming stale in mid-February.
Correspondence should be directed to:
Chester S. Zygmont, III (principal issuer contact)
Chief Financial Officer
4660 La Jolla Village Drive, Suite 100
San Diego, California 92122
Mobile Phone: 650-272-7018
Email: czygmont@revbiosciences.com
Joseph P. Galda, Esq. (counsel to the issuer)
J.P. Galda & Co.
40 East Montgomery Avenue, LTW 220
Ardmore, Pennsylvania 19003
Mobile Phone: 215-815-1534
Email: jpgalda@jpgaldaco.com
Please contact the undersigned with any questions or comments.
Very truly yours, | |
J.P. Galda & Co. | |
By: /s/ Joseph P. Galda |